fbpx
QQQ
+ 1.79
362.64
+ 0.49%
DIA
-0.94
351.56
-0.27%
SPY
+ 0.34
438.67
+ 0.08%
TLT
-0.20
149.84
-0.13%
GLD
+ 0.82
167.62
+ 0.49%

Thinking About Buying Stock Or Options In Target, Biogen Or Delta Air Lines?

June 8, 2021 10:08 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

One of the most common questions traders have about stocks is “Why Is It Moving?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Here are the latest analyst ratings and updates for Target, Biogen and Delta Air Lines.

  • UBS analyst Michael Lasser upgraded Target Corporation (NYSE:TGT) from Neutral to Buy and raised the price target from $210 to $265.
  • HC Wainwright & Co. analyst Andrew Fein maintained Biogen Inc (NASDAQ:BIIB) with a Buy and raised the price target from $305 to $452.
  • Baird analyst Brian Skorney upgraded Biogen from Underperform to Neutral and raised the price target from $216 to $382.
  • Citigroup analyst Mohit Bansal upgraded Biogen from Sell to Neutral and raised the price target from $200 to $440.
  • Morgan Stanley analyst Matthew Harrison maintained Biogen with an Overweight and raised the price target from $343 to $455.
  • Morgan Stanley analyst Ravi Shanker maintained Delta Air Lines, Inc. (NYSE:DAL) with an Overweight and raised the price target from $70 to $73.
  • Jefferies analyst Sheila Kahyaoglu upgraded Delta Air Lines from Hold to Buy and raised the price target from $50 to $60.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

Thinking About Buying Stock Or Options In Tilray, Ocugen, Biogen Or Snowflake?

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving. read more

Why Biogen Shares Are Trading Higher Today

Biogen Inc (NASDAQ: BIIB) shares are trading higher by 3.2% at $419.81 after SVB Leerink maintained an Outperform on the stock and raised its price target from $380 to $475. read more

Cassava Sciences Stock Soars In Anticipation Of Alzheimer's Data: A Technical Analysis

On Thursday, Cassava Sciences, Inc (NASDAQ: SAVA) smashed through a resistance level at $117.54, made 21 years ago between its initial public offering date of June 14, 2000 and December of that year. read more

Carnival And American Airlines Lead The SPY Higher Tuesday

U.S. indices were trading higher Tuesday amid a rebound in reopening stocks, which dipped Monday amid Delta variant concerns. read more